Fortimedix, headquartered in the southern province of The Netherlands, is a global leader in the field of endovascular stents and an innovative product definition company, specialized in minimally invasive surgery. The company was founded in 1999 and has been successful in establishing professional, long-term relationships with customers and suppliers around the world, solidifying a competitive advantage and paving an efficient path for product success in an ever changing market.
Fortimedix offers a comprehensive range of product development and contract manufacturing services to medical device manufacturers, with full competence to take projects from the initial concept to manufacturing and beyond. More specifically, Fortimedix offers full in-house contract stent development & stent manufacturing capabilities in various materials (e.g. stainless steel, MP35N, L605 and NiTi) and related OEM manufacturing services. Fortimedix Surgical is committed to continuing the evolution of minimally invasive surgery by creating novel devices that capture the claimed benefits of single-port surgery. Visit www.fortimedixsurgical.com to learn more.
Through the knowledge of the Fortimedix team of experts, the company has access to over a century of valuable experience in the field of minimal invasive healthcare. We invest heavily in research & development which fosters innovation, enables continuous improvement, and fulfils our dedication to operational excellence. In combination with in-house testing laboratories and superior manufacturing capabilities, Fortimedix offers a complete Technology Platform enabling its customers to maximize flexibility and minimize risk, without incurring large internal fixed costs.